Trending Topic

20 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Article highlights There is growing clinical importance attributed to the development of metabolic dysfunction-associated steatotic liver disease in people with type 2 diabetes (T2D). Numerous international groups now advocate screening for advanced fibrosis in people with risk factors, such as T2D, using non-invasive biomarkers. This article explores the rationale to screen for advanced fibrosis in people with risk […]

Donna Cryer, GLI 2022: International NASH Day

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 4th 2022

Ahead of International NASH Day, we had the pleasure of meeting with the Global Liver Institute Founder, President and Chief Executive Officer Donna Cryer to discuss this year’s theme ‘Stop NASH Now’, and the importance of endocrinologists in the NASH patient journey.

Questions

  1. How does GLI help support patients and their endocrinologists? (0:28)
  2. This year’s theme for International NASH Day is Stop NASH Now. Can you tell us about the meaning behind that theme? (1:13)
  3. Where can endocrinologists be most impactful in the NASH patient journey? (2:33)
  4. What is the relationship between diabetes and fatty liver disease/NASH? (4:02)

Disclosures: Donna Cryer has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup